Chen J - Search Results

1

Unique roles played by Acid-sensing ion channel 2.

Guo Y, Chen J, Li J, Cheng L, Lin N. Guo Y, et al. Among authors: chen j. Channels (Austin). 2015 Nov 9:0. doi: 10.1080/19336950.2015.1106653. Online ahead of print. Channels (Austin). 2015. PMID: 26552578 Free article.

2

Oncolytic adenovirus with MUC16-BiTE shows enhanced antitumor immune response by reversing the tumor microenvironment in PDX model of ovarian cancer.

Wang Q, Ma X, Wu H, Zhao C, Chen J, Li R, Yan S, Li Y, Zhang Q, Song K, Yuan C, Kong B. Wang Q, et al. Among authors: chen j. Oncoimmunology. 2022 Jul 1;11(1):2096362. doi: 10.1080/2162402X.2022.2096362. eCollection 2022. Oncoimmunology. 2022. PMID: 35800156 Free PMC article.

3

Clinical features and prognostic factors analysis of intravenous leiomyomatosis.

Chen J, Bu H, Zhang Z, Chu R, Qi G, Zhao C, Wang Q, Ma X, Wu H, Dou Z, Wang X, Kong B. Chen J, et al. Front Surg. 2023 Jan 30;9:1020004. doi: 10.3389/fsurg.2022.1020004. eCollection 2022. Front Surg. 2023. PMID: 36793517 Free PMC article.

4

Successful pregnancy after complete resection of leiomyomatosis peritonealis disseminate without recurrence:a case report with next-generation sequencing analysis and literature review.

Bu H, Jin C, Fang Y, Ma Y, Wang X, Chen J, Chen L. Bu H, et al. Among authors: chen j, chen l. World J Surg Oncol. 2020 May 2;18(1):85. doi: 10.1186/s12957-020-01857-0. World J Surg Oncol. 2020. PMID: 32359372 Free PMC article. Review.

5

CDCA8, targeted by MYBL2, promotes malignant progression and olaparib insensitivity in ovarian cancer.

Qi G, Zhang C, Ma H, Li Y, Peng J, Chen J, Kong B. Qi G, et al. Among authors: chen j. Am J Cancer Res. 2021 Feb 1;11(2):389-415. eCollection 2021. Am J Cancer Res. 2021. PMID: 33575078 Free PMC article.

6

TTK inhibition increases cisplatin sensitivity in high-grade serous ovarian carcinoma through the mTOR/autophagy pathway.

Qi G, Ma H, Li Y, Peng J, Chen J, Kong B. Qi G, et al. Among authors: chen j. Cell Death Dis. 2021 Dec 7;12(12):1135. doi: 10.1038/s41419-021-04429-6. Cell Death Dis. 2021. PMID: 34876569 Free PMC article.

7

HJURP Promotes Malignant Progression and Mediates Sensitivity to Cisplatin and WEE1-inhibitor in Serous Ovarian Cancer.

Dou Z, Qiu C, Zhang X, Yao S, Zhao C, Wang Z, Chu R, Chen J, Chen Z, Li R, Wang K, Liu P, Liu C, Song K, Kong B. Dou Z, et al. Among authors: chen j, chen z. Int J Biol Sci. 2022 Jan 1;18(3):1188-1210. doi: 10.7150/ijbs.65589. eCollection 2022. Int J Biol Sci. 2022. PMID: 35173547 Free PMC article.

8

Targeting TCF19 sensitizes MSI endometrial cancer to anti-PD-1 therapy by alleviating CD8⁺ T cell exhaustion via TRIM14-IFN-β axis.

Ma X, Wang Q, Sun C, Agarwal I, Wu H, Chen J, Zhao C, Qi G, Teng Q, Yuan C, Yan S, Peng J, Li R, Song K, Zhang Q, Kong B. Ma X, et al. Among authors: chen j. Cell Rep. 2023 Aug 29;42(8):112944. doi: 10.1016/j.celrep.2023.112944. Epub 2023 Aug 10. Cell Rep. 2023. PMID: 37566545 Free article.

9

SHCBP1 promotes cisplatin resistance of ovarian cancer through AKT/mTOR/Autophagy pathway.

Qi G, Ma H, Teng K, Gai P, Gong Y, Chen J, Luo X, Kong B. Qi G, et al. Among authors: chen j. Apoptosis. 2024 Oct 13. doi: 10.1007/s10495-024-02027-3. Online ahead of print. Apoptosis. 2024. PMID: 39397124

10

Splicing Factor DDX23, Transcriptionally Activated by E2F1, Promotes Ovarian Cancer Progression by Regulating FOXM1.

Zhao C, Li Y, Qiu C, Chen J, Wu H, Wang Q, Ma X, Song K, Kong B. Zhao C, et al. Among authors: chen j. Front Oncol. 2021 Dec 13;11:749144. doi: 10.3389/fonc.2021.749144. eCollection 2021. Front Oncol. 2021. PMID: 34966670 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137,892 results

Search Page

Filters